Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $142.80 | Total: $714.00 |
| 1 | 10 | $120.96 | Total: $1,209.60 |
| 1 | 25 | $102.48 | Total: $2,562.00 |
| 1 | 50 | $87.36 | Total: $4,368.00 |
| 1 | 100 | $75.60 | Total: $7,560.00 |
Overview
Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection.
Chemical Properties
| Molecular Formula | C41H50N8O8 |
| Molecular Weight | 782.88 |
| CAS Numbers | 1312608-46-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C([C@@H](NC(OC)=O)C(C)C)(=O)N1[C@H](C=2NC(C3=C4C(=C(C=C3)C5=CC=C(C=C5)C=6NC(=NC6)[C@H]7N(C([C@@H](NC(OC)=O)[C@@H](C)C)=O)CCC7)OCO4)=CN2)CCC1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Gao Y, Kong F, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China A single-arm, open-label, phase 3 trial. Liver Int. 2020 Nov;40[11] 2685-2693.